# Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

> **NCT00563186** · NA · COMPLETED · sponsor: **University of Calgary** · enrollment: 1514 (actual)

## Conditions studied

- Vancomycin Resistant Enterococci Infection
- Clostridium Difficile Infection
- Nosocomial Infection
- Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

## Interventions

- **OTHER:** Admission to a novel hospital ward

## Key facts

- **NCT ID:** NCT00563186
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 1514 (ACTUAL)
- **Last updated:** 2018-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00563186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00563186, "Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00563186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
